what is glp 1 medication made from GLP-1 Agonists - it? The GLP-1 revolution: What UAB

The future oral GLP-1 receptor agonists, incretin dual agonists, triple agonists, and other new oral metabolic products will become popular only if they prove themselves capable of producing sustained results in obesity disease, type 2 diabetes, hypertension, dyslipidemia, cardiovascular risks, and metabolic syndromes through their effectiveness and safety

Ozempic or Wegovy

Yaribeygi H, Maleki M, Butler AE, et al

The plan still needs approval from federal regulators before taking effect

If successful, they could dramatically improve convenience and potentially increase treatment uptake

Diabetes Metab Syndr Clin Res Rev 11:225230 Higashijima Y, Tanaka T, Yamaguchi J, Tanaka S, Nangaku M (2015) Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury